HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

XAV939: from a small inhibitor to a potent drug bioconjugate when delivered by gold nanoparticles.

Abstract
Nanoparticles as potential drug delivery vectors are drawing more attention every day. Here, we used gold nanopspheres (AuNSs) to selectively target the Wnt signaling pathway in human oral squamous cell carcinoma (HSC-3) cells. In a previously conducted study, XAV939, a small inhibiter, was found to strongly regulate the Wnt pathway by inhibiting the tankyrase enzyme and subsequent stabilization of cytoplasmic axin levels. In the present study, conjugating XAV939 molecules to AuNSs is found to enhance its potency by at least 100 times over its free form in killing HSC-3 cancer cells. Additionally, XAV 939 uptake studies have demonstrated an enhanced XAV939 bioconjugate delivery to the targeted cells compared to the passive cellular diffusion of the free drug at the same concentration. Furthermore, our study revealed that drug delivery and cytotoxicity are directly related to the size of the functionalized nanoparticles.
AuthorsMarwa M Afifi, Lauren A Austin, Megan A Mackey, Mostafa A El-Sayed
JournalBioconjugate chemistry (Bioconjug Chem) Vol. 25 Issue 2 Pg. 207-215 (Feb 19 2014) ISSN: 1520-4812 [Electronic] United States
PMID24409808 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Heterocyclic Compounds, 3-Ring
  • XAV939
  • Gold
Topics
  • Carcinoma, Squamous Cell (pathology)
  • Cell Death (drug effects)
  • Cell Line, Tumor
  • Flow Cytometry
  • Gold (chemistry)
  • Heterocyclic Compounds, 3-Ring (administration & dosage, pharmacology)
  • Humans
  • Metal Nanoparticles (administration & dosage, chemistry)
  • Microscopy, Electron, Transmission
  • Mouth Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: